lrg biomarker (inTEST Corporation)
90
Structured Review
inTEST Corporation
lrg biomarker
Lrg Biomarker, supplied by inTEST Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/lrg+biomarker/lrg+biomarker/pm39155217-23-0-17
Average 90 stars, based on 1 article reviews
Lrg Biomarker, supplied by inTEST Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/lrg+biomarker/lrg+biomarker/pm39155217-23-0-17
Average 90 stars, based on 1 article reviews
lrg biomarker - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Biomarker Discovery:Article Title: Early change in serum leucine-rich α-2-glycoprotein predicts clinical and endoscopic response in ulcerative colitis. Article Snippet: ROC analysis showed that LRG the had numerically highest AUC (0.82) for predicting subsequent endoscopic improvement (Fig. 7D-F) with a cutoff of 19.7 ( Article Title: Efficacy of serum leucine-rich alpha-2 glycoprotein in predicting findings of Crohn's disease small bowel lesion in capsule endoscopy. Article Snippet: Cutoff: 85, AUC: 0.68 CDAI 1-Specificity 1.0 0.9 0.8 0.7 0.6 0.5 0.4 0.3 0.2 0.1 0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1.0 Se ns iti vi ty Cutoff: 14 μg/mL, Article Title: Early change in serum leucine-rich α-2-glycoprotein predicts clinical and endoscopic response in ulcerative colitis. Article Snippet: Conclusions: LRG can be an early-phase biomarker predicting subsequent clinical and endoscopic response to induction therapy. ( Article Title: Combination of leucine-rich alpha-2 glycoprotein and fecal markers detect Crohn's disease activity confirmed by balloon-assisted enteroscopy. Article Snippet: Conclusions: The biomarkers LRG, fecal calprotectin, and fecal hemoglobin can serve as noninvasive and accurate tools for assessing activity in CD patients confirmed by BAE, especially when used in combination. ( Article Title: Leucine-rich alpha-2 glycoprotein is useful in predicting clinical relapse in patients with Crohn's disease during biological remission. Article Snippet: LRG is a useful biomarker for predicting prognosis, even in patients with intestinal stenosis, or Article Title: Early change in serum leucine-rich α-2-glycoprotein predicts clinical and endoscopic response in ulcerative colitis. Article Snippet: At week 1, LRG and CRP were significantly lower in the |